MedTrace Logo

Community-based Management of Chronic Obstructive Pulmonary Disease in Nepal

NCT03797768 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1438

Last updated 2021-01-28

No results posted yet for this study

Summary

Chronic Obstructive Pulmonary Disease (COPD) is the fourth most important cause of death worldwide and is one of the commonest non-communicable diseases (NCDs) in Nepal. The presence of risk factors like indoor and outdoor air pollution, the high prevalence of smoking and lack of general awareness of COPD makes it a serious public health concern. However, no attempt has been made in Nepal to estimate its burden and address the disease at the community level. This community-based cluster randomized controlled study aims to fulfil that gap through mobilization of Female Community Health Workers (FCHVs) who will be trained to perform a certain set of health promotion activities aimed at prevention of the disease and its progression. Baseline and follow-up surveys will be conducted to compare the intervention and control groups. This study has the potential to generate evidence in helping address NCDs in Nepal and also other similar resource-limited countries.

Conditions

Interventions

BEHAVIORAL

Behavioural-FCHV Visit

Female Community Health Volunteer will visit selected households on average 3 times a year for providing health promotion messages on improving lung health status and avoiding risk factors to COPD.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Tara Ballav Adhikari, MScPH · Department of Public Health, Aarhus University, Aarhus, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-25
Primary Completion
2021-05-10
Completion
2021-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03797768 on ClinicalTrials.gov